Physician Assistant Careers

FOR IMMEDIATE RELEASE CONTACT:
OCTOBER 5, 2010 JESSICA LAURINO
480-540-6518

MIDWESTERN UNIVERSITY to Host Open House for those interested in Physician Assistant careers as Part of
2010 National PA Week

[Glendale, Arizona- MIDWESTERN UNIVERSITY] will participate in National PA Week from October 6-12. This PA open house is a chance to those to come and visit/tour the Midwestern campus as well as gain the knowledge of what a PA does, and the road to becoming a PA. First and second year PA’s will be conducting this event and are willing to answer any questions following a prepared presentation by the PA students themselves.
Approximately 75,000 physician assistants (PAs) work in almost all medical settings and specialties across the country, and they provide a range of medical care to Americans. The role of PAs is vital to the success of health care, especially now that approximately 32 million Americans will have access to health care due to the Patient Protection and Affordable Health Care Act that was passed in March. Well before health reform, there were more than 250 million visits to PAs by patients in 2008.
National PA Week is an opportunity for the community to better understand the value of PAs. Without PAs, providers in hospitals, private practice, nursing homes, correctional institutions and many other health care settings would simply be overrun. Studies show that PAs deliver high-quality care and that patients are highly satisfied with PA-provided care.
In celebration of PA week, Midwestern University- Glendale campus is going to hold various events on and off campus to help spread the word of what exactly a PA does in the health care setting. On campus, booths will be set up on October 7th during the lunch hour 11am-1pm teaching the other health professional programs about PA week and a PA’s role. Also, a toiletry drive is being held to help support a homeless shelter in Tucson, AZ which is in conjunction with ASAPA (Arizona State Association of Physician Assistants). Most importantly, the students of Midwestern are offering an open house to those who are interested in becoming PA’s.
WHO: Anyone interested in becoming a PA
WHAT: Open House/Tour of Midwestern followed by a presentation and Q&A session
WHEN: October 7th 2010 6pm-8pm
WHERE: Midwestern University- Glendale Campus, Meet in Ocotillo hall
If you are planning on attending please RSVP by Thursday AM Oct 7th to:
Jessica Laurino PAS-1 jessica.laurino@azwebmail.midwestern.edu
All students at Midwestern are members of the American Academy of Physician Assistants (AAPA). For more questions about the general PA profession http://www.aapa.org

UA Best Buddies – Campus Club

Have you always been interested in helping people with disabilities and making new friends? If so, read on!
UA Best Buddies is a campus club that seeks to improve the lives of people with disabilities by forming mutually enriching one-to-one friendships between a person with and a person without a disability. UA Best Buddies gives UA students a unique fristhand opportunity to drastically change lives. For more general information please visit bestbuddies.org.
For those interested in learning more about the UA chapter, we will have our first NEW MEMBER ORIENTATION:

WHAT: UABB New Member Orientation
WHEN: Monday, Sept 27th, 2010 at 4:00pm
WHERE: Gould Simpson, 601

If you cannot make it to the meeting, don't forget to sign up for our listserv to receive all of our latest info! Listserv instructions:
To subscribe, send an email to listserv@listserv.arizona.edu with a blank subject and the following in the message body (make sure to insert your name in the ‘firsname’ and ‘lastname’ fields):

subscribe uabestbuddies firstname lastname

If you have any questions or concerns, please email me at astseng@email.arizona.edu!

International Alliance for the Prevention of AIDS (IAPA)

International Alliance for the Prevention of AIDS (IAPA)
Are you interested in an unforgettable experience on the other side of the world?
Do you want to help others in a meaningful and significant way while gaining new cultural understanding?
The International Alliance for the Prevention of AIDS (IAPA) Summer Volunteer Program may be what you have been searching for. Every year, we select a group of students from Arizona universities to volunteer in Southeast India for two months in an effort to stem the growth of HIV transmission rates. Our volunteers are trained as teachers, spreading HIV/AIDS prevention education to high schools and high-risk communities. We also work closely with local orphanages and develop our own additional side projects to make an impact in other aspects of the HIV/AIDS epidemic. Our volunteers will meet and interact with people from the US and from India with whom they will be able to form lasting relationships.
This is a life-changing opportunity that will not only contribute greatly to your personal growth, but will also stand out on any resume for medical or graduate school.
If you are interested in this program, please check out the IAPA website at http://www.iapaindia.org. To see more lives you could impact, you can also check out http://www.sheltertrust.org and http://www.peace-trust.in.
Any questions can be directed to iapa2011@gmail.com. We are also on Facebook, at http://www.facebook.com/?ref=logo#!/group.php?gid=150924141592499&ref=ts, where you can find immediate updates about the program.
Informational sessions will be hosted in the near future, so be on the lookout for more emails about IAPA!

UA Career Services Kick-Off

Jobs! Jobs! Jobs! Find out more at the UA Career Services Kick-Off.
Back by popular demand: Government agencies showcasing their opportunities. Get off the bench and into the game at the UA Career Services’ Kick-Off on Wednesday, September 8th .

· Get your resume critiqued by professionals and employers.
· Get psyched (and prepare) for the upcoming career fair.
· Start (or complete) Campus Interviewing registration.
. Learn more about the resources available to you.
· Talk to representatives from the FBI, C.I.A., I.R.S., U.S. State Department and Teach for America about hiring opportunities in their agencies.
· Receive a list of employers attending the event.
· The first 100 students who practice their One-Minute Commercial at the Mock Interview booth will receive a free UA red cap.
· All that and you can grab a piece of pizza and soda too (while supplies last).

Never mind the big tailgate party. What you’ll find at the Career Services' Kick-Off is solid information that is critically important to YOUR future.
Jump Start Your Job Search TODAY!

UA CAREER SERVICES’ KICK-OFF
Sponsored by Valero Energy Corporation
Wednesday, September 8
11am to 2pm
Student Union Memorial Center
Suite 411

Student Health Advisory Committee

The Student Health Advisory Committee (SHAC) is currently accepting applications for the 2010-2011 school year. We are an organization under ASUA acting as the liaison between Campus Health and the student body. This year, SHAC has the biggest agenda in its history: we will be pursuing policy initiatives such as a tobacco free university; we have partnered up with the Arizona Cancer Center and College of Public Health to make this dream a reality. We will also begin a large endeavor with our Pandemic and Epidemic Prevention Team , which will have its first program to vaccinate the homeless against seasonal and pandemic influenza for the homeless. We have also partnered up with the Sarver Heart Center to spread the word of chest compression only cardiopulmonary resuscitation(CPR)developed here at the UA's Sarver Heart Center; as a benefit, every SHAC member will be trained in CPR for free, with one member being paid to learn to teach CPR. We will also host our annual Run for Your Life 5k Run/Walk as well as other projects, many focused on sports nutrition, fitness, sexual health, mental health and raising money for well deserved charities. We are looking for 30 highly motivated individuals to join our team aimed at bringing health and wellness to our community. We are looking for all different types of people, with all different skills, including website design, and marketing, or any health related knowledge. The only things required for our applicants are a strong work ethic and an intense passion for health and helping others. If you are interested in applying, the application can be found on our website at (shac.asua.arizona.edu). Applications are due by September 3rd in the ASUA office front desk, Student Union, 3rd floor.

Suit Alleges Mayo Overbilled for Pathology Services, Justice Department Joins Suit

The below news item has been circulating for a couple of weeks following a suit originally filed about 3 years ago.  Several folks have asked me what I know about this.  

Did Mayo intentionally defraud the government of potentially millions of dollars for frozen sections not performed?

It is a difficult question to answer and I really do not know how strong the lawsuit claim is.  

I do not think Mayo intentionally would do this but it is a complicated issue.

The story actually begins about 100 years ago when Dr. Louis B. Wilson, credited with being the Father of Research at Mayo Clinic, developed the first techniques to rapidly fix tissue for sectioning during surgery at the request of Dr. William Mayo or what we recognize in pathology as the "frozen section". His techniques live on at Mayo today much like they did over 100 years ago.  The history of the procedure has recently been reviewed with reference to the original article by Dr. Wilson.

Enough history.  Fast forward about 100 years and according to Mayo's GME FAQ's on the frozen section practice it mentions: "The frozen section rotation is probably best thought of as neither a frozen section rotation nor a general surgical pathology rotation, and perhaps that is why residents have come to refer to it as the “sink” rotation. The volume and variety of specimen material seen by residents while on the sink is comparable to what would be seen during a general surgical pathology rotation at a large medical center, yet the workflow is that of a frozen section laboratory. " The site goes on to mention " In the Mayo frozen section labs, a single-color toluidine stain is used because it produces a fast and easily readable stain. The toluidine blue stain produces a slightly different staining pattern compared to H&E, but the morphologic features are inherent to the tissue."

I never understood "morphologic features are inherent to the tissue".  Histology is artifact.  We create it with dyes - a chemical process creates purple nuclei and pink cytoplasm.  In the case of toluidine blue stain, as above, it is largely monochromatic with less contrast than traditional H&E stains, whether frozen or fixed.  

Until recently, with increasing pressure from CAP inspectors, slides reviewed at frozen may not have had a corresponding H&E permanent slide to review for frozen-final correlation.  The tissue used in the frozen section was "blocked" without making an H&E slide.  Again, the practice is unique and would be difficult to validate in many other labs if one takes an objective view.

It also turns out that given the water based nature of the stain and the stain itself it was difficult to make a "permanent" slide for later review as the stain may continue to permeate the tissue.

Given the unique practice, essentially a general surgical pathology practice with final diagnosis made on frozens at the time of surgery rather than "permanent" sections,  issues related to frozen section slides, blocks and permanent slides could all potentially complicate billing algorithms as the suit alleges.  

While the parties bringing forth the suit and the Justice Department are looking at the letter of the law, a persistent question will remain whether whatever may have happened here in regards to billing was justifiable (i.e. cost effective) given potential lack of need for second surgeries, immediate intraoperative staging and overall costs to the system for additional laboratory technical and professional resources to generate additional slides, reviews and reports as compared to outcomes in a "frozen section = final diagnosis" practice alone.  This practice is highlighted on Mayo's breast cancer website:

"Mayo Clinic physicians may use frozen section evaluation of tissue during breast cancer surgery to determine whether all of the cancer has been removed. Mayo Clinic's unique frozen section pathology laboratory provides rapid, accurate microscopic analysis of tissue while the patient is in surgery. Mayo surgeons know if they have achieved negative margins (removed all the cancer) while the patient is still in the operating room. Frozen section analysis may prevent the need for patients to undergo additional surgery."

It should be noted from a similar story out of Minneapolis -- "The Justice Department indicated in a September 21 court filing that it intends to intervene in the allegation that the Mayo Clinic billed for services that were not performed. The department will not become involved, however, in the claims that the Mayo Clinic improperly obtained laboratory accreditation and failed to retain histopathology slides for the appropriate time period.


Courtesy of genomeweb.com:

The Justice Department has joined a lawsuit against the Mayo Clinic alleging it submitted fraudulent claims to Medicare and Medicaid for thousands of surgical pathology tests over 10 years that its labs never performed.

The government's position, filed this week under the federal False Claims Act in a US District Court in Minneapolis, said that "over the course of the last 10 years, Mayo has routinely billed Medicare, Medicaid and other federally sponsored health care programs for surgical pathology services that have not been performed," according to the Pittsburgh Tribune-Review.

The suit, which was originally filed in November 2007 by attorney and neurologist David Ketroser, accuses Mayo of billing Medicare for permanent specimen slides and for examining the slides, "even though no slides were prepared or examined," the paper says. "Instead, the suit charges, Mayo routinely prepared only frozen section slides, which were not retained."

The suit also claims Mayo failed to comply with federal regulations that require clinical lab to retain pathology slides for 10 years.

The plaintiffs in the suit include former Mayo patients, survivors of deceased Mayo patients, and Minnesota attorney David Ketroser.

Mayo officials did not respond to a request for comment, according to the Tribune-Review.

A few days after its original report, the paper wrote that Mayo officials said the Clinic reimbursed the government for what the paper called "billing errors" on the pathology tests.

Mayo spokesman Bryan Anderson said Minnesota-based Mayo discovered the errors three years ago — "long before Mayo became aware that the sealed complaint [against it] had been filed" — and "voluntarily" refunded $242,711, the paper said.

The total amount of Mayo's alleged fraudulent billing was not immediately clear.

 

Answer to Case of the Week 57

Answer: Entamoeba histolytica/dispar

Congratulations to all of the viewers who wrote in with the answer – you recognized that the morphologic features and size were consistent with these two closely related protozoa. E. histolytica is a recognized pathogen, although it only causes disease in approximately 10% of the people it infects. E. dispar, on the other hand, is generally considered a non-pathogen. Unfortunately, the two are morphologically indistinguishable, and require isoenzyme, antigen, or molecular methods to distinguish them. The only exception to this is when E. histolytica trophozoites are seen invading the bowel wall on histologic section, or contain ingested RBCs on ova and parasite exam. No ingested RBCs are seen in this case, so it is not possible to differentiate between the two organisms.

The answer to the second part of the question is that an asymptomatic host could still be infected with either E. histolytica or E. dispar (remember that most E. histolytica infections are asymptomatic).

Finally, just to make life difficult for clinical parasitologists, there is now a THIRD species of Entamoeba which is morphologically indistinguishable from E. histolytica and E. dispar. Entamoeba moshkovskii is now recognized to be a wide spread environmental organism and occasional human parasite. Therefore, I suppose that the most correct answer to this case is “Entamoeba histolytica/dispar/moshkovskii!!

Digital Pathology Focuses on Forward Push Amid Regulatory Uncertainty

Digital pathology continues to generate industry buzz, especially with numerous heavy hitters like Aperio, Olympus, and Bioimagene displaying a significant presence at this week’s CAP ’10 meeting. Standardization is also moving forward with the recent release of the medical image exchange standard Supplement 145 from The Digital Imaging and Communications in Medicine (DICOM) Standards Committee, of which the CAP is a member.

However, while there are over a dozen FDA 510(k) clearances for digital analysis of immunohistochemistry procedures, the waiting game continues for how the agency wants to regulate digitalization of hematoxylin and eosin (H&E) slides using whole slide imagng (WSI) systems, according to Steve Potts, PhD, CEO of digital pathology service provider Flagship Biosciences (Flagstaff, AZ). Potts recently spoke at a histology image analysis webinar on regulation and digital pathology hosted by Denver-based Digital Pathology Consultants.

There has been no word from the FDA since October 2009, when stakeholders—including the CAP and digital pathology companies—testified before the agency’s Hematology and Pathology Devices Advisory Committee during a public comment period to address oversight of whole slide imagining (WSI) systems.

One key issue is whether these systems should be subjected to the agency’s Class II or Class III requirements. While Class II products are frequently “cleared” by the 510(k) process, Class III devices must go through the PMA process. This process requires more investment—both in money and time—as the device has to be “approved” as safe and effective after undergoing clinical trials. The CAP testified at the hearing, primarily on recommendations for validating WSI systems.

Dr. Potts speculates that WSI will likely be considered Class II devices and will need to be cleared by the FDA. He added that subsequent pathology procedures using this device will then be considered laboratory developed tests (LDTs), as the regulatory filings will likely be for specific applications. However, this could further delay momentum, as the FDA is currently crafting LDT oversight framework.

Nevertheless, Dr. Potts believes that once these regulatory barriers are negotiated, digital pathology will move ahead at breakneck speed. “When this technology starts to move into labs and pathology practices, it will come fast,” he predicted.

 

PathXchange – There is an App for that

PathXchange is proud to offer PathXchange app for Apple iPhone and iPad, featuring case content from PathXchange and articles and blogs from LWW Pathology Network. Whether you are a practicing pathologist or a pathologist in training, this is a must have app for your iPhone, iPod Touch, or iPad.

With over 8600 members from 168 countries and hosting over 2000 pathology cases, PathXchange is the largest online pathology community. PathXchange iPhone app allows members and non-members to view the most interesting and educational cases in Pathology. Enabled by the latest digital pathology technologies, many of these cases contain whole slide images that you can view using your iPhone as a virtual microscope!

LWW Pathology Network is an online resource brought to you by Wolters Kluwer Lippincott Williams & Wilkins (LWW) that delivers current full-text articles from the entire LWW pathology journal collection in one convenient location. Journal content is sorted into continuously updates topic-based channels.

 

  

 

    

 

Download the PathXchange app for your iPhone, iPod Touch and iPad!

 

Register Now for Pathology Visions and Pre-Conference Workshops

Pathology Visions will be offering pre-conference workshops to enhance your conference experience.

Workshops are only open to registered attendees of Pathology Visions and require registration. Select your requested workshops during online registration or email info@pathologyvisions.com. Space is limited, so reserve your seats early.

 


2010 Pre-Conference Workshops

Sunday, October 24, 1:00 – 5:00 p.m.
Sheraton Hotel and Marina (Pathology Visions host hotel)

The pre-conference workshops are a great way to kick-start your Pathology Visions experience!


Digital Pathology for Quality Assurance, presented by Jared Schwartz, M.D., Ph.D., F.C.A.P.

Healthcare organizations spanning the globe are adopting digital pathology for improved patient care.

Discover the resounding benefits that Aperio’s digital pathology solutions can bring to your organization. The majority of digital pathology users in the clinical market have an Aperio system and as the leader in digital pathology healthcare solutions, Aperio is ready to help you move toward the adoption of digital pathology for improved patient care. Our experienced team has installed over 700 total systems in 30 countries, 68% of which are installed within hospitals and reference labs. 

One of the most critical aspects of a hospital’s charter is enhancing patient care and ensuring patient safety.  Learn how Aperio’s healthcare solutions can promote quality assurance for enhanced patient care.

To learn more about Aperio, 
visit http://www.aperio.com.


CompuCyte’s Laser Scanning Cytometry for Quantitative Pathology – 
The Modern Pathologist’s Best Friend

iGeneration LSC technology enables objective, fully automated investigation of tissue and cytology specimens based on precise, accurate and reproducible analysis of cellular biomarkers on a single-cell level. This workshop will provide an overview of applications employed in biopharmaceutical preclinical/ clinical studies and research pathology, ranging from basic 2-color chromatic applications to state-of-the art multi-parameter experiments on samples stained with combinations of chromatic and fluorescent stains. A virtual demonstration of the iCys® Research Imaging Cytometer will highlight its unique cytometric analysis of pathology specimens.

To learn more about CompuCyte, 
visit http://www.compucyte.com.


Tumor Morphological and Biomarker Profiling with Definiens Tissue Studio 2.0

One year ago at Pathology Visions, Definiens launched Definiens Tissue Studio, the most advanced digital pathology image analysis solution for biomarker translational research. One year later, Definiens Tissue Studio has become the gold standard in digital pathology image analysis; providing flexibility, ease of use, rapid analysis times, and accurate cell-by-cell biomarker and morphological quantification.

This talk will focus on the application of Definiens Tissue Studio 2.0 for tumor biomarker and morphological profiling of bright field and immunofluorescence digital pathology images

To learn more about Definiens, 
visit http://www.definiens.com.


Slide Sharing Made Easy
 

Introducing Pathology@home, the fastest and easiest way to share your digital slides with colleagues anywhere, for research or consultation. Bring your favorite digital slides on a USB key or drive to see how easy it is!

To learn more about Objective Pathology, 
visit http://www.objectivepathology.com.

 

Reminder: Pathology Visions 2010 – San Diego Oct 24-27

 Date:October 24-27, 2010
Location: Sheraton San Diego Hotel and Marina, San Diego, CA
Organizer: Digital Pathology Association (DPA)

Why Attend Pathology Visions

The annual meeting brings together members of the healthcare and scientific community to discuss real-world, practical applications and learn about the latest advances in digital pathology. Choose from presentations on major topics in focused tracks: Clinical and Research & Drug Development. Special topic areas within these tracks will include Education, IT, and more.

Who Should Attend

If you are involved or interested in the exciting world of digital pathology, Pathology Visions is the conference for you. The annual meeting is intended for health care professionals involved in delivering pathology, including:

• Clinical pathologists
• Veterinary/Tox pathologists
• Pharmaceutical/biotech researchers
• Laboratory technicians, managers, and directors
• Pathology educators
• Histologists
• Healthcare IT professionals 

All attendees will be enriched through comprehensive presentations, stimulating discussions and workshops, poster sessions, and the Pathology Visions Exhibit Hall.

For more information and registration visit:

 http://www.pathologyvisions.com

 

Pathology Informatics Boston — A fully digital, pathology conference

Today's post is guest written by Dr. Steven Potts, MBA, CEO of Flagship Biosciences.  My many thanks to Steve for his thoughtful commentary and personal thoughts on the meeting.  Comments on your experiences are welcome if you attended the meeting.

As someone who enjoys fishing high mountain streams and rivers, a great place to find fish is at the convergence of multiple streams, where the interacting currents churn new nutrients and food up to the surface. Pathology Informatics combined three streams -- Advancing Information Management in the Clinical Laboratory (AIMCL) and Advancing Pathology Informatics, Imaging and the Internet (APIII), which merged upstream previously, and Lab InfoTech Summit, a LIS oriented conference. The convergence was brilliant, and brought new ideas into this event.

For North American adopters of digital pathology, there are now two leading conferences, Pathology Visions in San Diego and Pathology Informatics. Pathology Informatics was clearly a product of years of collaboration, dialog, and competition in the Academy, an academic-led conference. It is likely that Path Visions will be driven by industry and Path Informatics by the Academy. What a great time for both conferences, and it will be good for the pathology community to continue to have distinctions between them. 

Digital pathology and whole slide imaging was a key part of the conference, but not the central focus. This is also healthy, the goal is a fully digital, pathology laboratory, not digital pathology by itself. Whole slide images are part of the lab, but must fit into other technologies covered at this conference, like LIS integration, integrated databases, workflow, sample tracking, and integration with radiology.

My conference highlight was the Histopathology Image Analysis (HIMA) session on Sunday afternoon. It was a packed eight hours of leading innovators in pathology image analysis. The churning of new ideas by the multiple university collaborations in computer science and pathology departments are clearly bearing fruit. The bottleneck is larger annotated sample sets, but impressive inroads are being made on new pattern recognition techniques on hard problems (automated Gleason scoring will cause any image analysis scientist to go running back to the IHC ER/PR/HER2 refuge for cover). The continuing need for these exciting techniques is for validation on larger datasets, and this will require vision and funding to produce these large databases (are you listening, granting agencies?).

It was also great to see more usage of the technologies in pharmaceutical clinical trials, as pharma/biotech will continue to be the playground where new companion diagnostics tests are developed. It was impressive to hear of multiple academic medical centers collaborating in pathology and computer science. The new tests will not likely be as “easy” as ER/PR/HER2, so it is great to see many innovative image analysis ideas. Unfortunately, despite the conference being very well attended, and located near Cambridge, the current biotech center of the world, there were few pharma image analysis attendees. But this is not the fault of the content nor program, people have to find out they missed the party, to motivate attendance the following year. 🙂

There were a number of exciting software innovations by university researchers, ranging from image analysis to QA algorithms for scanning quality. I would encourage the community to think about the distribution of their ideas, as the first thing we want to do when reading a image analysis publication is to try out the technique on our own slides. A number of vendors now have software development kits that allow extensions and other approaches for getting technology into the hands of the users. Whatever route is taken, allowing users to be able to access the software is as important as the publication itself. This is what made academic gene/protein sequence bioinformatics so powerful was the ability to get the technology quickly into the hands of the users. 

The electronic poster presentation sessions were well-done, and covered a broad range of topics. Not having to print a poster at Kinko's late at night is a definite personal benefit, although the interaction of a powerpoint presentation to a large audience is certainly much different from a one-on-one discussion in front of a large paper poster. I see a parallel to moving from glass to digital slides in pathology presentations, certainly makes life easier, but it does fundamentally change the communication dynamics.

This conference represented a major step forward in pathology convergence, particularly between pathology and computer science. The rivers from other modalities, including radiology and cytometry (!) can wait until later years downstream for integration. My personal opinion is that a fully digital, pathology lab will be a bigger, more immediate benefit to the patient than the pathology labs sucked (or suckered) into radiology PACS systems. 

My compliments to all involved with Pathology Informatics. I look forward to next year!  

 

Steve Potts

Digital Pathology Services

 

vRad to acquire NightHawk

EDEN PRAIRIE, MN – Virtual Radiologic (vRad), a national radiology practice and developer of radiologist workflow technology, will acquire competitor NightHawk Radiology in a $170 million deal.

Scottsdale, Ariz.-based NightHawk Radiology (NASDAQ: NHWK), provides radiology solutions to radiology groups across the country. vRad will acquire all of the outstanding common stock of NightHawk Radiology Holdings, Inc. for $6.50 per share in cash, which is double NighHawk's closing stock price of $3.25 per share.
 
The combination of vRad and NightHawk will result in enhanced services to radiology groups and hospitals across the country, accelerating vRad's stated commitment to optimize radiology's critical role in the delivery of patient care, vRad executives said. The combined entity will have 325 radiologists serving nearly 2,700 healthcare facilities across all 50 states and reading approximately 6 million studies annually. More than 75 percent of the affiliated radiologists will be fellowship-trained subspecialists.

"Local radiology practices and hospitals are under intense pressure to deliver the highest quality care in the most efficient manner possible," said vRad President and CEO Rob Kill. "The need for expanded access, improved quality, and reduced costs is clear. Both vRad and NightHawk have been delivering these benefits in partnership with local radiologists for many years."

"We are pleased to deliver significant, immediate value to our stockholders through this transaction," said NightHawk President and CEO David Engert. "The combination of our collective assets will enable us to better meet our clients' rapidly expanding needs and will enhance our ability to partner with local radiologists to address the needs of local hospitals, physicians and the patients they serve."

Upon the completion of the transaction, Kill will continue to serve as president and CEO of the combined organization. Engert will remain as a board adviser following the close of the transaction. The remainder of the leadership team will be drawn from the management teams of both companies.

Company executives expect the transaction will be completed  in the first quarter of 2011, subject to customary closing conditions, including the approval of NightHawk's stockholders.

 

Aperio’s CMO wins Pathologist of the Year

Jared N. Schwartz, MD, PhD, FCAP, Selected as 2010 Pathologist of the Year by the College of American Pathologists

NORTHFIELD, Ill., Sept. 27 /PRNewswire/ -- Jared N. Schwartz, MD, PhD, FCAP, of Charlotte, N.C., was named the 2010 Pathologist of the Year at a ceremony held on September 26, 2010, in Chicago at CAP '10 — THE Pathologists' Meeting™.

Dr. Schwartz received the award, the College of American Pathologists' highest honor, in recognition for his strong leadership of the College during his term as president from 2007 to 2009, as well as his tireless contributions to the CAP over the years by serving as a member and chair of numerous committees and councils, including the International, Compensation, Finance, Strategic Planning, and National Meeting Planning Committees and the Council on Scientific Affairs.

"It is always an honor to receive the recognition of one's peers, and I thank you for this award," said Dr. Schwartz.  "I met so many incredible people that otherwise would never have crossed my path, and I learned that we all have something to contribute to improve the common good."

Dr. Schwartz has held numerous leadership positions within the College, having served as CAP president-elect and secretary-treasurer. He also served as chair of both the Finance Committee and the Ad-Hoc Task Force on National Preparedness. He has been an active member of numerous other CAP ad hoc committees, as well. Dr. Schwartz is a longtime member of the CAP Spokespersons Network, and he currently serves as an alternate delegate for the World Association of Societies of Pathologists and Laboratory Medicine (WASPaLM).

Previously, Dr. Schwartz was president of the CAP Foundation Board, as well as a member of the CAP/JCAHO Lab Committee and the Microbiology Resource Committee. In addition, Dr. Schwartz served as chair of the Council on Scientific Affairs, the CAP Web Strategy Task Force, and the Program and Program Evaluation Committee.

Dr. Schwartz is the chief medical officer for Aperio Technologies, Inc., and he currently serves as a consulting professor in the Department of Pathology at Stanford University in California. Prior to his position with Aperio, Dr. Schwartz was the director of the Department of Pathology and Laboratory Medicine at Presbyterian Healthcare in Charlotte, North Carolina, where he served as a staff pathologist and chief of the medical staff. At Presbyterian Healthcare, he chaired the Pathology Peer Review and was a member of the Executive Committee of the Medical Board, the Cancer Center Strategic Planning Committee, the Breast Cancer Advisory Committee, and the CEO Physician Leadership Group. He previously was a medical examiner in Durham County, North Carolina.

Dr. Schwartz earned his BS in microbiology and his MSc in mycology from The Ohio State University in Columbus. He received his MD from Duke University Medical School in Durham, followed by his PhD in pathology from Duke University Graduate School. Dr. Schwartz completed his internship, fellowship, and residency at Duke University Medical Center in the Department of Pathology, where he also served as chief resident from 1976-1977.

The College of American Pathologists is a medical society serving more than 17,000 physician members and the laboratory community throughout the world.  It is the world's largest association composed exclusively of board-certified pathologists and is widely considered the leader in laboratory quality assurance.  The College is an advocate for high-quality and cost-effective patient care.

SOURCE: College of American Pathologists

 

Digital Pathology Association to Host Sixth Annual Pathology Visions Conference

Industry Thought Leaders Gather to Learn About Advances in Digital Pathology

The Digital Pathology Association (DPA), a non-profit organization committed to the advancement of digital pathology applications in healthcare, invites interested pathology professionals to join them for the sixth annual Pathology Visions conference, to be held October 24-27 in San Diego, CA, at the Sheraton Hotel and Marina.

Pathology Visions brings together pathologists and industry thought leaders for a showcase of the latest in digital pathology technology and applications in healthcare. Registrants will participate in three days of multi-track educational sessions covering innovative topics in digital pathology, white paper sessions, roundtable discussions, scientific poster sessions, workshops, networking events, and the Pathology Visions Exhibit Hall, in which product solutions from the leading digital pathology providers in the industry will be featured.

“Pathology Visions provides a unique forum for all types of healthcare professionals and service providers interested in learning about digital pathology solutions and applications,” said Dirk G. Soenksen, president of the Digital Pathology Association. “We are excited to have a dynamic program with such a distinguished group of speakers this year from a broad range of digital pathology interest areas.”

Sylvia Asa is the Keynote Speaker for Pathology Visions 2010. She is Pathologist-in-Chief and Medical Director of the Laboratory Medicine Program at the University Health Network. As head of the largest pathology department in Canada, Dr. Asa has made innovative changes to the practice of the discipline, with emphasis on subspecialization, automation, electronic initiatives and telepathology.

In addition, over 35 breakout sessions will cover a variety of applications in the topic areas of Clinical, Research, Informatics, Education, and IT. A sampling of session topics include:

  • Validating digital slides for clinical use: when is image quality good enough?
  • IT issues to consider when implementing telepathology links with remote locations
  • Validation of digital pathology applications in regulated study environments
  • Developing quantitative tissue-based assays to assess target inhibition in oncology drug discovery and development
  • The histopathology lab as an imaging engine: automation, workflow, and quality assurance in support of universal whole-slide imaging
  • Implementation of subspecialty whole-slide image teaching sets for pathology residency education

A detailed agenda for the conference, including session descriptions and registration information for Pathology Visions is available at www.pathologyvisions.com. For additional information contact Jennifer Levy at (760) 539-1192.

About the DPA

The mission of the Digital Pathology Association is to facilitate education and awareness of digital pathology applications in healthcare. Members will be encouraged to share best practices and promote the use of the technology among colleagues in order to demonstrate efficiencies, awareness, and its ultimate benefits to patient care. For additional information about sponsorship and membership opportunities, visit the association’s website at:  http://www.digitalpathologyassociation.org.

If you would like more information, please contact Michael F. Ward at (317) 816-1619 or email  info@digitalpathologyassociation.org.

 

Clinical pathology laboratories will soon archive digital pathology images in their hospitals’ PACS

September 27, 2010 Dark Report:

New Digital Pathology DICOM Standards Will Expand Pathologists’ Use of Whole Slide Images 

Digital pathology moves one step forward toward true “plug and play” with the recent approval of the DICOM supplement 145. These are the technical specifications that support whole-slide digital pathology images. Approval of these standards now makes it possible for clinical laboratories and pathology groups to store digital pathology images in a form that is compatible with the same DICOM archive systems used by hospitals and other providers to store radiology images.

Read more.

 

Transforming Clinical Lab Middle Managers into Top-Performing Team Contributors!

Send your lab’s best management talent and most promising young leaders to this two-day intensive!

 

Register NOW

Transforming Lab Middle Managers into Top-Performing Team Contributors!

Laboratory Managers Leadership Workshop Coming this fall to a city near you:

Four Great Cities! Four Convenient Dates!

October 12-13, 2010
Baltimore Hilton Baltimore BWI Airport Hotel

October 26-27, 2010
San Francisco Hilton San Francisco Airport Hotel

November 2-3, 2010
Chicago DoubleTree Chicago O'hare

November 16-17, 2010
Miami Hilton Garden Inn Miami Airport Hotel


Register NOW

Jeff Smith - Management Training

Meet Your Leader and Guide

Jeff Smith brings over 20 years of experience as an executive in human resources and operations in both for-profit and not-for-profit organizations. He currently works with Slone Partners providing Leadership Development for Laboratory Professionals and teaches for Titan Management University. Smith was a key team member in the transformation of the management culture at topperforming Carilion Laboratories in Roanoake, Virginia, and worked for Capital One. As Director of Human Resources for Carilion Labs, he had a seminal role in designing and driving culture change, implementing sucession planning, and creating coaching tools for laboratory leaders. Smith has earned high marks from laboratory professionals who participated in recent lab management educational programs offered by THE DARK REPORT. He teaches a collaborative approach that helps laboratory managers, directors, and administrators determine their vision, then craft a plan for achieving this vision in their professional and personal lives. His area of expertise in HR includes: organizational development, organizational change, succession planning, executive coaching, team building, leadership development, and recruiting. Jeff graduated cum laude with a BBA from James Madison University in management and history. He holds an MA from George Washington University in Human Resource Development. Additionally, Jeff graduated from Georgetown University with an Executive Coaching and Leadership certificate and became a fellow of the Advisory Board in 2006. Jeff is a certified Professional Coach (PCC) by the International Coaching Federation.

Register NOW


It's our Super-Special Tuition for the Extra-early Bird! Register by August 1st, 2010 and your tuition will be only:

$995.00

Full Registration is normally:

$1,495.00

Register NOW

Who Should Attend

Workshop is appropriate for up-and-coming middle managers, senior managers, and administrators; any lab manager tasked with achieving business goals and boosting staff productivity, such as:

  • Operational department managers
  • Clinical department managers
  • Pathology administrators
  • Director-level managers, including operations, logistics, IT, sales, marketing, client support
  • Administrators at all levels
  • Clinical section managers
  • Supervisors on the management track
  • Supervisors at all levels

Register NOW 

Two days of hands-on learning, useful case studies, and great networking


  • New ways to engage your lab’s culture that turbocharge productivity and profits!
  • Proven methods that motivate lab staff to achieve stretch goals on time and on budget!
  • Charting your personal and organizational vision—setting a road map for success!
  • Increase your lab’s productivity by improving your lab’s middle managers’ effectiveness!
  • How to evaluate your team and identify the barriers to increased performance and profitability
  • Becoming the better coach: why it works and how to pick your best coaching candidates!
  • Know your preferred leadership style and how to use it to motivate staff and improve teamwork!
  • Succession planning essentials: prepare your lab for the coming wave of retiring managers and staff!
  • Best ways to develop talented staff members with limited time and a bare-bones budget!
  • Effective methods to retain top producers with a management career path they appreciate!
  • Simple steps to teach your managers better people-management skills.
  • Achieving the high-performance culture in your lab: unleashing your managers’ creativity!
  • Understand how to get the wrong people off your bus!
  • Secrets to leading Baby Boomer’s, Gen-Xer’s, and Millennials!
  • It’s all about vision: best ways to align your lab’s growth goals with your personal career path!
  • Recognize your lab’s superstars and how to energize them to greater achievement!


Aperio to Showcase Digital Pathology Solutions at CAP ’10

Company Offering “What’s Your Path?” Digital Pathology Assessment

Aperio, will be demonstrating its digital pathology systems and solutions at the annual College of American Pathologists CAP ‘10 conference to be held September 26-29, 2010 at the Hyatt Regency Chicago.

Aperio, the leading technology innovator in digital pathology with a global installed base of more than 700 total systems in 30 countries, nearly 70% of which are installed within hospitals and reference labs, will be exhibiting in booth #211. The company provides the most comprehensive open-architecture solution for digital pathology, enabling streamlined pathology workflow with integrated instruments, software and services. Their award-winning ScanScope® slide scanning systems, Spectrum Plus™ image management (PACS) software and SecondSlide® digital slide sharing service increase laboratory efficiency and help organizations improve quality assurance and patient care while achieving more rigorous compliance with CAP and CLIA guidelines.

Company representatives will be offering complimentary individual consultations, with appointment-based assessments available by the company’s chief medical officer, Dr. Jared Schwartz, for organizations interested in learning about the unique benefits of digital pathology. A “What’s Your Path?” consultation will help interested organizations:

  • Pinpoint digital pathology applications that provide near-term value
  • Identify return-on-investment (ROI) opportunities
  • Evaluate illustrative workflow diagrams
  • Understand intangible benefits in an AP lab environment
  • Comply with CAP/CLIA guidelines
  • Determine next steps for experiencing the benefits of digital pathology in your organization

Attendees are encouraged to RSVP for a digital pathology assessment by e-mailing events@aperio.com. Walk-ins are welcome on an as-available basis during exhibit hours.

A kiosk in the exhibit booth will allow attendees to experience Aperio’s SecondSlide digital slide sharing service that enables the secure, encrypted exchange of whole-slide images, photomicrographs, documents and commentary. The SecondSlide digital slide sharing service is presently available to pathologists free of charge; for more information please visit http://www.secondslide.com.

 

Flagship Biosciences and Visiopharm Announce Joint Partnership in High-Throughput Histoinformaticsâ„¢

European technology leader in histoinformatics™ and American digital pathology services firm announce a partnership for delivering quantitative results faster to pharmaceutical and medical device customers

Quote startWhole slide stereology is no longer something that scientists delivering quantitative pathology results can afford to ignore.Quote end

Flagstaff, AZ (PRWEB) September 17, 2010

In recognition of the opportunities in Histoinformatics™, covering whole slide stereology and whole slide tissue pattern recognition for improving the measurement of efficacy and toxicity in pharmaceutical and medical device development, two leading firms announce a joint partnership.

Flagship Biosciences LLC is a US based pathologist-owned contract research organization that utilizes whole slide imaging to rapidly deliver quantitative data to its pharmaceutical and medicaldevice customers. Visiopharm is a Denmark basedHistoinformatics™ software company with a leading science pedigree in stereology and image analysis, with patented technology in the emerging area ofwhole slide stereology and in tissue pattern recognition capabilities and workflows.

Flagship Biosciences has selected Visiopharm’s advanced image analysis modules and stereology applications as its primary platform for delivery of quantitative results to pharmaceutical and medical device clients. “The ability to offer advanced digital pathology analysis for efficacy and toxicity measurements is critical to both drug and device development. With the emerging opportunities in whole-slide stereology, we needed a software partner that would allow us to rapidly and effectively analyze large batches of slides, and are very pleased with the Visiopharm software system,” said David Young, President and Chief Pathologist of Flagship Biosciences. “We consider Visiopharm’s software to be the best of breed for advanced image analysis, and also to have the fastest pace of innovation in the industry.”

“Visiopharm has many years of scientific leadership in stereology,” said Steve Potts, CEO of Flagship Biosciences. “Whole-slide stereology is no longer something that scientists delivering quantitative pathology results can afford to ignore. Visiopharm’s patent protected Whole Slide Stereology technology makes stereology several orders of magnitudes faster, more accessible and cost-effective. With these novel innovations, it is only a matter of time until stereology will become widespread and adopted in regular pharmaceutical and device tissue analysis. The biggest surprise we have had in working with Visiopharm is how many of the fundamental technical strengths of stereology can be applied in standard image analysis workflows – the radical improvements in tissue sampling approaches or the sophisticated pre- and post-processing of histology pattern recognition workflows. We see many applications for this technology in common brightfield and fluorescence analysis workflows.”

“We are excited to be working with a pathologist-led digital CRO in the delivery of advanced software solutions,” said Michael Grunkin, CEO of Visiopharm. The Flagship team is unique in the close interaction they have between their pathologists, image analysis experts, regulatory groups, and their customers. Flagship’s ability to deliver image analysis results while working within regulatory guidelines in preclinical toxicology and oncology companion diagnostics helps to expand the use of image analysis and stereology into new areas. With the unique combination of knowledge in our two companies, we will soon be able to provide the software and services required to establish a full-fledged preclinical GLP and 21 CFR 11 clinical trials compliant high-throughput Histoinformatics™ platform for providing end-points based on image analysis /pattern recognition and stereology. We believe this will be very valuable for the biopharmaceutical industry in their endeavor to establish credible scientific data for making critical decisions” added Dr. Grunkin.

In the United States, Flagship Biosciences and Olympus America will be distributing Visiopharm software. Flagship will be assisting with pathologist and image analysis expert training in the use of the software for advanced image analysis workflows. Visiopharm’s expert stereology scientists will collaborate with Flagship in offering whole-slide stereology services.

About Visiopharm

Visiopharm is a leading provider of advanced software for quantitative microscopy for life sciences. Visiopharm software combines the strengths of image analysis and stereology in one platform. International pharmaceutical companies, biotech companies, universities, hospitals and contract research organizations are successfully using Visiopharm software for deriving scientifically, trustworthy data with high information content and outstanding efficiency.

About Flagship Biosciences

Flagship Biosciences LLC is a pathologist-owned company whose mission is to improve tissue assessment in pharmaceutical and medical device development. Flagship’s services include quantitative pathology assessment on-demand, low-cost digital pathology slide scanning, secure hosting, pathologist-supervised IHC and histology placement, and custom image analysis and companion diagnostics development. All of their services are reviewed and supervised by board-certified pathologists.

 

A Funny, Free Webinar on Image Analysis In Regulated Pathology

Sign up today for a free and funny webinar this Thursday, September 23rd at 12 PM EST, provided by http://www.thedigitalpathologywiki.com and it's sponsors titled, "Too Early = Too Late = Too Stupid:  The right time to use image analysis in regulated pathology".

Space is limited, register today @ https://www1.gotomeeting.com/register/829378304

Overview of Webinar: 
The computer  is a valuable pathologist tool, but not a patho-droid. In this hopefully humorous hour, you will hear why image analysis will enhance the professions of both veterinary and medical anatomic pathology and how to  use this tool effectively. 
  • Clinical and preclinical regulations you need to be aware of, as demystified as possible. 
  • How the computer thinks about image analysis, and how the most common biomarker algorithms work. 
  • Is the computer lying? Practical ways to evaluate algorithm performance. 
  • Putting pathologists back in charge - taming the patho-droid paranoia 

Hosted by Steve Potts, CEO of Flagship Biosciences: 

Dr. Potts joined Flagship from Aperio, where he was Vice President of Life Sciences. He managed worldwide sales and marketing in the biopharma segment, where his team achieved global adoption by nearly all of the largest pharmaceutical companies. He defined and led the GLP product development and validation services for the use of whole slide images in regulated preclinical and clinical trials studies, as well as the development of image analysis techniques for angiogenesis. Prior to Aperio, he was Head of Bioinformatics and Biostatistics at Quest Diagnostics Nichols Institute, where his team supported the development of In Vitro Diagnostics Multianalyte Assays (IVDMIA) in oncology and other therapeutic areas. He was a product manager at Accelrys, where he created a protein-ligand data management system for medicinal and computational chemists, crystallographers, and biologists to provide structural bioinformatics data across multiple pharmaceutical departments. He earned a Ph.D. and M.S. in Biological Engineering, and an MBA from the University of California at Davis, and a B.S. in Physics from Wheaton College, Illinois. He has over 20 peer-reviewed publications and patents.

 
Title: Too Early = Too Late = Too Stupid: The right time to use image analysis in regulated pathology
 
Date: Thursday, September 23, 2010
 
Time: 10:00 AM - 12:00 PM MDT

 

Space is limited, register today @ https://www1.gotomeeting.com/register/829378304